Skip to main content
DGX logo
DGX
(NYSE)
Quest Diagnostics Incorporated
$237.14-- (--)
Loading... - Market loading

Quest Diagnostics Incorporated (DGX) Stock Price & Financial Analysis

Quest Diagnostics Incorporated Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$235.38 - $238.92
52-Week High$247.19
52-Week Low$171.18
Open$235.38
Volume775.14K
Average Volume (3M)861.57K
Market Cap26.56B
Shares Outstanding112.00M
P/E Ratio (TTM)25.01
Forward P/E22.42
Price to Sales (P/S)2.30
Price to Book (P/B)3.36
EV/EBITDA14.12
Revenue (TTM)11.56B
Net Income (TTM)1.06B
Free Cash Flow (TTM)1.35B
EPS (TTM)$9.46
Profit Margin9.19%
Operating Margin14.19%
Return on Equity (ROE)13.44%
Debt to Equity0.71
50-Day MA$227.54
200-Day MA$201.08
52-Week Change29.24%
Annual Dividend$3.32
Dividend Yield1.40%
Payout Ratio35.09%
Last Dividend Ex-DateOct 6, 2026

Frequently Asked Questions About Quest Diagnostics Incorporated

What is the current stock price for DGX?

As of the latest trading session, DGX stock trades at $237.14. The 52-week range is $171.18–$247.19, with a day range of $235.38–$238.91.

What is the P/E ratio for DGX?

Quest Diagnostics Incorporated's trailing P/E ratio is 25.0, meaning investors pay $25.0 for every $1 of annual earnings. The forward P/E is 22.4, reflecting analyst expectations for future earnings. Quest Diagnostics Incorporated operates in the Healthcare sector.

Does DGX pay dividends?

Yes, Quest Diagnostics Incorporated pays a 1.40% annual dividend yield ($3.32 per share). The payout ratio is 35.1%. The last ex-dividend date was 2026-10-06.

What do analysts recommend for DGX?

Based on 3 analysts, the consensus for DGX is Buy.

What is the market cap of DGX?

Quest Diagnostics Incorporated's market capitalization is $26.56B, classifying it as a large-cap company. Quest Diagnostics Incorporated operates in the Healthcare sector within the Diagnostics & Research industry.